The Precision Peptide Genetic Test examines key variants like GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 that directly affect how your body responds to GLP-1 agonists
This allows the capsule to dissolve and the peptide to be absorbed with minimal competition, leading to potentially higher bioavailability
Aunque la evidencia preclnica sugiere efectos cardioprotectores, los beneficios cardiovasculares demostrados clnicamente provienen de estudios con agonistas del receptor de GLP-1 especficos (como liraglutida, semaglutida y dulaglutida), que han mostrado reduccin de eventos cardiovasculares mayores en pacientes con diabetes tipo 2
[DOI] [PubMed] [Google Scholar] 18.Hansen-Smith FM, Watson L, Lu DY, Goldstein I
Diarrhea and Constipation Both diarrhea and constipation are frequent side effects of GLP-1 medications